✦ LIBER ✦

The absorption and penetration of therapeutic agents from a Carbowax vehicle*

✍ Scribed by Meyers, Donald B. ;Nadkarni, M.V. ;Zopf, Louis C.

Publisher: Elsevier
Year: 1949
Weight: 409 KB
Volume: 38
Category: Article
ISSN: 0095-9553
DOI: 10.1002/jps.3030380416

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro release and in vivo penetration

In vitro release and in vivo penetration studies of a topical steroid from nonaqueous vehicles

✍ Robert E. Dempski; Joel B. Portnoff; Arthur W. Wase 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 2 views

Penetration of theophylline and adenosin

Penetration of theophylline and adenosine into excised human skin from binary and ternary vehicles: Effect of a nonionic surfactant

✍ Ron Kadir; Dov Stempler; Zvi Liron; Sasson Cohen 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Barbiturate Vehicles**From the Laborator

Barbiturate Vehicles**From the Laboratory of Pharmacology and Therapeutics of the University of Illinois, College of Medicine, and assisted by a grant from the American Pharmaceutaicl Association.

✍ Fantus, Bernard ;Dyniewicz, H.A. 📂 Article 📅 1936 🏛 Elsevier ⚖ 127 KB

Assessment of kininases in rheumatic dis

Assessment of kininases in rheumatic diseases and the effect of therapeutic agents

✍ Iftikhar A. Sheikh; Allen P. Kaplan 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 723 KB

Antimicrobial peptides from ranid frogs:

Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents

✍ J.Michael Conlon; Jolanta Kolodziejek; Norbert Nowotny 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 455 KB

A review of the therapeutic agents used

A review of the therapeutic agents used in the management of polycythaemia vera

✍ Mary Frances McMullin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

## Abstract The acquired clonal disorder Polycythaemia Vera leads to increased erythropoiesis, myelopoiesis and megakaryopoeisis. These anomalies result in an increased incidence of thromboembolic events, transformation to acute leukaemia and myelofibrosis. Treatments which aim to reduce the event